Lifang Cheng - Search Results

Year	Number of Results
2009	1
2010	2
2012	1
2013	1
2014	4
2015	3
2016	2
2017	4
2018	2
2019	1
2020	4
2021	3
2022	0

1

Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells.

Ma L, Diao L, Peng Z, Jia Y, Xie H, Li B, Ma J, Zhang M, Cheng L, Ding D, Zhang X, Chen H, Mo F, Jiang H, Xu G, Meng F, Zhong Z, Liu M. Ma L, et al. Among authors: cheng l. Adv Mater. 2021 Oct;33(43):e2104849. doi: 10.1002/adma.202104849. Epub 2021 Sep 18. Adv Mater. 2021. PMID: 34536044

2

Sparse multi-output Gaussian processes for online medical time series prediction.

Cheng LF, Dumitrascu B, Darnell G, Chivers C, Draugelis M, Li K, Engelhardt BE. Cheng LF, et al. BMC Med Inform Decis Mak. 2020 Jul 8;20(1):152. doi: 10.1186/s12911-020-1069-4. BMC Med Inform Decis Mak. 2020. PMID: 32641134 Free PMC article.

3

Bayesian nonparametric discovery of isoforms and individual specific quantification.

Aguiar D, Cheng LF, Dumitrascu B, Mordelet F, Pai AA, Engelhardt BE. Aguiar D, et al. Nat Commun. 2018 Apr 27;9(1):1681. doi: 10.1038/s41467-018-03402-w. Nat Commun. 2018. PMID: 29703885 Free PMC article.

4

Interaction of FLNA and ANXA2 promotes gefitinib resistance by activating the Wnt pathway in non-small-cell lung cancer.

Cheng L, Tong Q. Cheng L, et al. Mol Cell Biochem. 2021 Oct;476(10):3563-3575. doi: 10.1007/s11010-021-04179-1. Epub 2021 May 20. Mol Cell Biochem. 2021. PMID: 34018148

5

Study of the Correlation Between the Ratio of Diastolic to Systolic Durations and Echocardiography Measurements and Its Application to the Classification of Heart Failure Phenotypes.

Cheng L, Liao K, Wang Y, Lv F, Guo X, Zheng Y, Qin J. Cheng L, et al. Int J Gen Med. 2021 Sep 10;14:5493-5503. doi: 10.2147/IJGM.S324319. eCollection 2021. Int J Gen Med. 2021. PMID: 34531677 Free PMC article.

6

GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer.

Cheng L, Gou L, Wei T, Zhang J. Cheng L, et al. Int J Oncol. 2020 Sep;57(3):858-870. doi: 10.3892/ijo.2020.5086. Epub 2020 Jun 22. Int J Oncol. 2020. PMID: 32582960

7

An Optimal Policy for Patient Laboratory Tests in Intensive Care Units.

Cheng LF, Prasad N, Engelhardt BE. Cheng LF, et al. Pac Symp Biocomput. 2019;24:320-331. Pac Symp Biocomput. 2019. PMID: 30864333 Free PMC article.

8

cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery.

Wang Y, Hu W, Ding B, Chen D, Cheng L. Wang Y, et al. Among authors: cheng l. Colloids Surf B Biointerfaces. 2020 Oct;194:111195. doi: 10.1016/j.colsurfb.2020.111195. Epub 2020 Jun 12. Colloids Surf B Biointerfaces. 2020. PMID: 32619785

9

Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.

Hu Q, Wang Y, Xu L, Chen D, Cheng L. Hu Q, et al. Among authors: cheng l. Int J Nanomedicine. 2020 Apr 22;15:2751-2764. doi: 10.2147/IJN.S238536. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32368053 Free PMC article.

10

Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage.

Hu Q, Chen Q, Yan X, Ding B, Chen D, Cheng L. Hu Q, et al. Among authors: cheng l. Nanomedicine (Lond). 2018 Apr 1;13(7):749-767. doi: 10.2217/nnm-2017-0335. Epub 2018 Mar 12. Nanomedicine (Lond). 2018. PMID: 29528264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results